Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3460)
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
200
Price
$69.12
Total Value
$13.82K
Shares Held After
11,589
% of Holdings
1.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,512
Price
$68.23
Total Value
$103.16K
Shares Held After
11,789
% of Holdings
11.4%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
2,088
Price
$67.53
Total Value
$141.00K
Shares Held After
13,301
% of Holdings
13.6%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
6,200
Price
$66.69
Total Value
$413.46K
Shares Held After
15,389
% of Holdings
28.7%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
4,667
Price
$29.82
Total Value
$139.15K
Shares Held After
10,500
% of Holdings
30.8%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
5,333
Price
$29.83
Total Value
$159.09K
Shares Held After
15,167
% of Holdings
26.0%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
8,748
Price
$29.82
Total Value
$260.86K
Shares Held After
35,194
% of Holdings
19.9%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
10,000
Price
$29.92
Total Value
$299.16K
Shares Held After
45,111
% of Holdings
18.1%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
7,841
% of Holdings
23.5%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
15,345
% of Holdings
10.1%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
7,594
% of Holdings
18.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
456
Price
$72.67
Total Value
$33.14K
Shares Held After
105,212
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,356
Price
$72.08
Total Value
$169.82K
Shares Held After
105,668
% of Holdings
2.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
8,466
% of Holdings
23.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
8,011
% of Holdings
19.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,354
Price
$453.45
Total Value
$613.97K
Shares Held After
24,734
% of Holdings
5.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$6.28
Total Value
$261.61K
Shares Held After
1,774,781
% of Holdings
2.3%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
3,250
Price
$43.49
Total Value
$141.34K
Shares Held After
52,250
% of Holdings
5.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
33
Price
$453.45
Total Value
$14.96K
Shares Held After
7,284
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.77
Total Value
$18.85K
Shares Held After
1,059,029
% of Holdings
0.5%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
8,971
Price
$3.90
Total Value
$34.99K
Shares Held After
117,453
% of Holdings
7.6%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
5,000
Price
$20.70
Total Value
$103.50K
Shares Held After
43,415
% of Holdings
11.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$109.47
Total Value
$218.94K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$572.25
Total Value
$183.12K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$571.23
Total Value
$182.79K
Shares Held After
40,833
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
616
Price
$569.94
Total Value
$351.08K
Shares Held After
41,153
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,682
Price
$569.03
Total Value
$957.10K
Shares Held After
41,769
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,211
Price
$568.07
Total Value
$1.82M
Shares Held After
43,451
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$567.04
Total Value
$1.06M
Shares Held After
46,662
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,477
Price
$566.19
Total Value
$836.26K
Shares Held After
48,536
% of Holdings
3.0%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
116
Price
$26.00
Total Value
$3.02K
Shares Held After
31,001
% of Holdings
0.4%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
1,822
Price
$26.00
Total Value
$47.37K
Shares Held After
381,073
% of Holdings
0.5%
Moderna, Inc. (MRNA)
Hoge Stephen — President
Shares
53,336
Price
$48.40
Total Value
$2.58M
Shares Held After
1,477,997
% of Holdings
3.5%
AC Immune SA (ACIU)
Pfeifer Andrea — Director
Shares
10,000
Price
$2.79
Total Value
$27.93K
Shares Held After
3,820,288
% of Holdings
0.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$20.29
Total Value
$91.31K
Shares Held After
191,641
% of Holdings
2.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
8,000
Price
$20.29
Total Value
$162.34K
Shares Held After
196,141
% of Holdings
3.9%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
13,100
Price
$6.65
Total Value
$87.11K
Shares Held After
700,000
% of Holdings
1.8%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.95
Total Value
$2.79K
Shares Held After
910,143
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100
Price
$13.80
Total Value
$1.38K
Shares Held After
909,943
% of Holdings
0.0%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
100
Price
$63.52
Total Value
$6.35K
Shares Held After
33,377
% of Holdings
0.3%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
2,100
Price
$62.42
Total Value
$131.09K
Shares Held After
33,477
% of Holdings
5.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
4,800
Price
$61.56
Total Value
$295.49K
Shares Held After
35,577
% of Holdings
11.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$57.04
Total Value
$1.43M
Shares Held After
1,198,095
% of Holdings
2.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,100
Price
$1.02
Total Value
$5.20K
Shares Held After
285,866
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
Crombez Eric — Director
Shares
26,143
Price
$5.53
Total Value
$144.64K
Shares Held After
37,313
% of Holdings
41.2%
NovaBridge Biosciences (NBP)
Cao Sean Wuxiong — Director
Shares
21,399
Price
$1.99
Total Value
$42.58K
Shares Held After
35,073
% of Holdings
37.9%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
15,000
Price
$26.22
Total Value
$393.35K
Shares Held After
0
% of Holdings
100.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
15,580
Price
$6.91
Total Value
$107.66K
Shares Held After
700,000
% of Holdings
2.2%
AbCellera Biologics Inc. (ABCL)
Montalbano John S. — Director
Shares
20,000
Price
$4.77
Total Value
$95.40K
Shares Held After
241,000
% of Holdings
8.3%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
300,000
Price
$1.20
Total Value
$360.00K
Shares Held After
311,547
% of Holdings
96.3%
Showing 801–850 of 3460 transactions (page 17 of 70)